Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126133151 | 12613315 | 1 | I | 20160729 | 0 | 20160801 | 20160801 | DIR | 49.88 | YR | M | N | 0.00000 | 20160729 | Y | PH | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126133151 | 12613315 | 1 | PS | SOVALDI | SOFOSBUVIR | 1 | Oral | 006416 | 20170930 | 0 | 400 | MG | QD | ||||||
126133151 | 12613315 | 2 | SS | RIBASPHERE | RIBAVIRIN | 1 | Oral | D | D | AC0654Z | 20170130 | 0 | 600 | MG | BID | ||||
126133151 | 12613315 | 4 | C | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | 0 | ||||||||||||
126133151 | 12613315 | 6 | C | LYRICA | PREGABALIN | 1 | 0 | ||||||||||||
126133151 | 12613315 | 8 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
126133151 | 12613315 | 10 | C | REGLAN | METOCLOPRAMIDE HYDROCHLORIDE | 1 | 0 | ||||||||||||
126133151 | 12613315 | 12 | C | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | 0 | ||||||||||||
126133151 | 12613315 | 14 | C | ELAVIL | AMITRIPTYLINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
126133151 | 12613315 | 16 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | 0 | ||||||||||||
126133151 | 12613315 | 18 | C | VALIUM | DIAZEPAM | 1 | 0 | ||||||||||||
126133151 | 12613315 | 20 | C | ROPINIROLE. | ROPINIROLE | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126133151 | 12613315 | 1 | Hepatitis C |
126133151 | 12613315 | 2 | Hepatitis C |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126133151 | 12613315 | Burning sensation | |
126133151 | 12613315 | Confusional state | |
126133151 | 12613315 | Dizziness | |
126133151 | 12613315 | Extra dose administered | |
126133151 | 12613315 | Memory impairment | |
126133151 | 12613315 | Muscle spasms | |
126133151 | 12613315 | Psychomotor hyperactivity | |
126133151 | 12613315 | Rash | |
126133151 | 12613315 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
Event ID | CASEID | RPSR COD |
---|---|---|
126133151 | 12613315 | HP |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126133151 | 12613315 | 1 | 10 | DAY | ||
126133151 | 12613315 | 2 | 10 | DAY |